| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SCHRES.2005.05.010 |
| P698 | PubMed publication ID | 15964177 |
| P2093 | author name string | John Stewart | |
| Lynn E DeLisi | |||
| Anne L Hoff | |||
| Christine Svetina | |||
| Gail Shields | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuropsychology | Q3872 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 27-34 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Ten year longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia | |
| P478 | volume | 78 |
| Q35121033 | A comparison of the effectiveness of problem solving training and of cognitive-emotional rehabilitation on neurocognition, social cognition and social functioning in people with schizophrenia |
| Q37704414 | Altered language network activity in young people at familial high-risk for schizophrenia |
| Q92284973 | An Association Study on the Cognitive Function and the Cerebral Grey Matter Volume of Patients with First-Episode Schizophrenia |
| Q40955282 | Application of the Audio Recorded Cognitive Screen and its relation to functioning in schizophrenia |
| Q31095554 | Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? |
| Q64065371 | Childhood Trauma in Schizophrenia: Current Findings and Research Perspectives |
| Q35991098 | Cognitive Performance and Long-Term Social Functioning in Psychotic Disorder: A Three-Year Follow-Up Study |
| Q37614666 | Cognitive deficits in recent-onset and chronic schizophrenia |
| Q36957121 | Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial |
| Q33959179 | Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment |
| Q33566109 | Cognitive impairment in affective psychoses: a meta-analysis |
| Q95586193 | Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations |
| Q33566114 | Cognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond |
| Q39463534 | Cognitive remediation in schizophrenia |
| Q94337965 | Cognitive remediation therapy plus standard care versus standard care for people with schizophrenia |
| Q94355322 | Cognitive remediation therapy plus standard care versus standard care for people with schizophrenia |
| Q50963926 | Core dysfunction in schizophrenia: electrophysiology trait biomarkers. |
| Q33597674 | Course of neurocognitive deficits in the prodrome and first episode of schizophrenia |
| Q51042364 | Deficient maturation of aspects of attention and executive functions in early onset schizophrenia. |
| Q51875346 | Deteriorated visual backward masking in the shine-through effect in adolescents with psychosis. |
| Q34805258 | Diabetes and cognitive deficits in chronic schizophrenia: a case-control study |
| Q92238326 | Early Substance Use Cessation Improves Cognition-10 Years Outcome in First-Episode Psychosis Patients |
| Q60939124 | Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality |
| Q42735871 | Effects of Cognitive Enhancement Therapy on Employment Outcomes in Early Schizophrenia: Results From a Two-Year Randomized Trial |
| Q35739005 | Effects of Endurance Training Combined With Cognitive Remediation on Everyday Functioning, Symptoms, and Cognition in Multiepisode Schizophrenia Patients |
| Q30362549 | Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study. |
| Q39412337 | Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms |
| Q37788304 | Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. |
| Q50953838 | Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis. |
| Q50610322 | Functioning in early and late stages of schizophrenia. |
| Q52657910 | Hyper- and Hypomentalizing in Patients with First-Episode Schizophrenia: fMRI and Behavioral Studies. |
| Q35065374 | IQ trajectory, cognitive reserve, and clinical outcome following a first episode of psychosis: a 3-year longitudinal study |
| Q38403090 | Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin |
| Q51896040 | Increased positive thought disorder with illness duration in patients with schizophrenia. |
| Q35878916 | Intact relational memory and normal hippocampal structure in the early stage of psychosis |
| Q38123594 | Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders |
| Q37791235 | Intellectual functioning and the long-term course of schizophrenia-spectrum illness |
| Q33411428 | Is schizophrenia a neurodegenerative disorder? |
| Q41857458 | Is there a degenerative process going on in the brain of people with Schizophrenia? |
| Q44074275 | Is there change in intelligence quotient in chronically ill schizophrenia patients? A longitudinal study in twins discordant for schizophrenia. |
| Q47683336 | Karolinska Scales of Personality, cognition and psychotic symptoms in patients with schizophrenia and healthy controls |
| Q38396447 | Kraepelin revisited: schizophrenia from degeneration to failed regeneration. |
| Q85076813 | Level and pattern of neuropsychological functioning in early-onset psychoses |
| Q45899470 | Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone. |
| Q57152586 | Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings |
| Q26770497 | Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review |
| Q36292901 | Longitudinal changes in prospective memory and their clinical correlates at 1-year follow-up in first-episode schizophrenia |
| Q88752064 | Longitudinal stability of cognitive control in early psychosis: Nondegenerative deficits across diagnoses |
| Q22241267 | Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature |
| Q33762467 | Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? |
| Q64065882 | NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality |
| Q36377842 | Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients |
| Q34081360 | Neurocognition in schizophrenia: a 20-year multi–follow-up of the course of processing speed and stored knowledge |
| Q33890155 | Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study |
| Q50621798 | Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert? |
| Q51053046 | Neurocognitive prediction of illness knowledge after psychoeducation in schizophrenia: results from the Munich COGPIP study. |
| Q91654068 | Neuroprogression across the Early Course of Psychosis |
| Q37626099 | Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study |
| Q92142268 | Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder |
| Q37115582 | Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up |
| Q56992231 | Neuropsychological impairments predict the clinical course in schizophrenia |
| Q47156248 | Neuropsychological performance as endophenotypes in extended schizophrenia families from the Central Valley of Costa Rica |
| Q30466264 | Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state |
| Q35321513 | New visual information processing abnormality biomarker for the diagnosis of Schizophrenia |
| Q51967657 | Preliminary neuropsychological findings in individuals at high genetic risk for schizophrenia. |
| Q64067792 | Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients |
| Q50720901 | Psychomotor and cognitive deficits as predictors of 5-year outcome in first-episode schizophrenia. |
| Q22251476 | Schizophrenia, “Just the Facts”: What we know in 2008 |
| Q36210656 | Schizophrenia: from epidemiology to rehabilitation |
| Q37346444 | Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths |
| Q38381963 | Selective deficits in semantic verbal fluency in patients with a first affective episode with psychotic symptoms and a positive history of mania |
| Q59330239 | Studying and modulating schizophrenia-associated dysfunctions of oligodendrocytes with patient-specific cell systems |
| Q37217597 | Ten year neurocognitive trajectories in first-episode psychosis |
| Q97595530 | Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort |
| Q34254426 | Testing trait depression as a potential clinical domain in schizophrenia |
| Q59103215 | The Effectiveness and Applicability of Compensatory Cognitive Training for Japanese Patients with Schizophrenia: A Pilot Study |
| Q39306530 | The Experience of Cognitive Impairment in People with Psychosis |
| Q35053407 | The Longitudinal Course of Gross Motor Activity in Schizophrenia - Within and between Episodes |
| Q37076180 | The Maudsley early onset schizophrenia study: cognitive function over a 4-year follow-up period |
| Q38123067 | The effects of physical exercise in schizophrenia and affective disorders |
| Q21129355 | The impact of environmental factors in severe psychiatric disorders |
| Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
| Q30478849 | The relationship between preattentive sensory processing deficits and age in schizophrenia patients |
| Q37903740 | The role of the cerebellum in schizophrenia: from cognition to molecular pathways |
| Q47916430 | Thought Disorder in Schizophrenia and Bipolar Disorder Probands, Their Relatives, and Nonpsychiatric Controls |
| Q37696307 | What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis |
| Q84511388 | [Cognitive disorders in schizophrenic patients] |
| Q86423209 | [First-episode psychosis, cognitive difficulties and remediation] |
Search more.